Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPAAC: Antibiotic Effects on Gut Microbiota
NCT04084106Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Sep 2019
- Primary completion
- Nov 2022
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of phenoxymethylpenicillin, amoxicillin, clavulanic acid in pneumonia, lower respiratory tract infection (LRTI), sponsored by Uppsala University. Started Sep 2019; status: completed.
02
Drugs
phenoxymethylpenicillinamoxicillinclavulanic acid
03
Conditions
pneumonialower respiratory tract infection (LRTI)
Beyond the preview
Go deeper on NCT04084106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04084106.